(Q52253915)

28 April 2018

title

A logistic dose-ranging method for phase I clinical investigations trials. (English)

1 reference

28 April 2018

main subject

phase I clinical trial

0 references

author name string

Murphy JR

series ordinal

1

1 reference

28 April 2018

Hall DL

series ordinal

2

1 reference

28 April 2018

publication date

1 November 1997

1 reference

28 April 2018

Journal of Biopharmaceutical Statistics

published in

1 reference

28 April 2018

volume

7

1 reference

28 April 2018

issue

4

1 reference

28 April 2018

page(s)

635-647

1 reference

28 April 2018

Design and analysis of phase I clinical trials

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10543409708835213

Continual reassessment method: a practical design for phase 1 clinical trials in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543409708835213

A comparison of two phase I trial designs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543409708835213

Estimating the probability of toxicity at the recommended dose following a phase I clinical trial in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543409708835213

The continual reassessment method in cancer phase I clinical trials: a simulation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543409708835213

10.1080/10543409708835213

21 January 2018

Identifiers

DOI

1 reference

28 April 2018

release_ulsds2dvanhxxgwbrooswvwqta

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ulsds2dvanhxxgwbrooswvwqta

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9358335

1 reference

28 April 2018